ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
CStone’s MEK inhibitor approved for trials in China
pharmaceutical-technology
August 01, 2018CStone Pharmaceuticals has announced its CS3006, a small molecule inhibitor of mitogen-activated protein kinase (MEK), has received investigational new drug approval for clinical trials from the China National Drug Administration (CNDA). This comes only t
Pharma Sources Insight July 2025
